Stocks and Investing Stocks and Investing
Fri, May 12, 2023
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (VYNE) at Strong Buy and Held Target at $28 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Louise Chen Maintained (VYNE) at Buy with Increased Target to $9 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Glenn Schorr Maintained (BAC) at Buy with Decreased Target to $35 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (AZO) at Buy on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Mike Matson Reiterated (AXNX) at Strong Buy and Held Target at $73 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (YETI) at Buy with Increased Target to $48 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Matt Koranda Maintained (YETI) at Hold with Increased Target to $43 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Feldman Reiterated (WMT) at Buy and Held Target at $53 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (WMT) at Hold with Increased Target to $52 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Wolleben Maintained (WMG) at Buy with Decreased Target to $24 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (ATXS) at Strong Buy and Held Target at $20 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Laura Chico Reiterated (ATXS) at Buy and Held Target at $26 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
John Ransom Downgraded (AVAH) to Hold on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
A.J. Rice Reiterated (AVAH) at Sell and Held Target at $1 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (ASM) at Strong Buy with Increased Target to $1.5 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Judah Frommer Reiterated (ATAI) at Buy and Held Target at $9 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Upgraded (AWR) to Hold and Held Target at $94 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Saket Kalia Maintained (ZS) at Hold with Decreased Target to $127 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Craig Irwin Downgraded (ADSE) to Hold and Decreased Target to $3 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Ronald Josey Maintained (ACVA) at Strong Buy with Increased Target to $19 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Thomas Singlehurst Downgraded (BFAM) to Hold and Increased Target to $101 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Michael Blum Maintained (BE) at Hold with Decreased Target to $20 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (BBWI) at Buy and Held Target at $52 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Tony Butler Reiterated (BCAB) at Strong Buy and Held Target at $25 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Maury Raycroft Upgraded (ALLK) to Strong Buy and Increased Target to $9 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Reiterated (ALXO) at Strong Buy and Held Target at $30 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
David Begleiter Maintained (APD) at Strong Buy with Decreased Target to $325 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $50 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
Yatin Suneja Maintained (ANAB) at Strong Buy with Increased Target to $45 on, May 12th, 2023
[ 12:00 AM ] - WOPRAI
David Nierengarten Reiterated (ANAB) at Hold and Held Target at $29 on, May 12th, 2023

David Nierengarten Reiterated (ANAB) at Hold and Held Target at $29 on, May 12th, 2023


Published on 2024-10-28 03:44:08 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Reiterated "AnaptysBio, Inc." (ANAB) at Hold and Held Target at $29 on, May 12th, 2023.

David has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Anupam Rama of "JP Morgan" Maintained at Sell with Decreased Target to $31 on, Wednesday, April 12th, 2023
Contributing Sources